Can Globus Medical Stock Rally 30% After This Dip?
Globus Medical (GMED) shares fell 19.1% since November 4, 2026, after lowering its 2026 revenue forecast. Historically, the stock has rallied a median 39.3% within a year after similar drops. Revenue declined 0.7% in Q3 2026, with full-year revenue forecast cut to $3.09B. Management expects new products to drive growth in 2027.



